Q32 Bio issues pre-funded warrants to purchase common stock
Q32 Bio Inc. filed an 8-K exhibiting pre-funded warrant terms dated May 26, 2026, allowing holders to purchase common shares at specified exercise prices. The offering expands the company's capital raising toolkit through derivative securities.
View filing at SEC.gov →